Drugs / Jinghua Weikang Capsule
Jinghua Weikang Capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05320133 | Jun 2022 → Nov 2024 | Helicobacter pylori infectious disease | Peking University First Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jinghua Weikang Capsule | “This study is to evaluate the efficacy and safety of the Jinghua Weikang Capsule (a Chinese patent medicine for peptic ulcer and gastritis) containing quadruple therapy” NCT05320133 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “a Chinese patent medicine for peptic ulcer and gastritis” NCT05320133 ↗ |